Literature DB >> 2297397

Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome.

C R Ashby1, L A Carr, C L Cook, M M Steptoe, D D Franks.   

Abstract

The effects of plasma and an aqueous plasma fraction from patients with premenstrual syndrome (PMS) and control subjects on the uptake of 5-hydroxytryptamine (5-HT) in washed human platelets and rat forebrain synaptosomes were studied. Pre- and postmenstrual samples of unextracted plasma from the control group significantly enhanced platelet uptake of 5-HT. In contrast, an aqueous fraction following extraction of the plasma with organic solvents caused a dose-dependent decrease of 5-HT uptake. Plasma obtained from patients with PMS caused less stimulation of 5-HT uptake compared to plasma from the control group. The aqueous fraction of premenstrual plasma from patients tended to inhibit 5-HT uptake to a greater extent than a similar plasma fraction from controls. The inhibition of 5-HT uptake was associated with an increase in Km. Aqueous plasma fractions from both groups also inhibited 5-HT uptake in brain synaptosomes. However, there were no significant differences between groups. The results of the platelet study suggest that there may be quantitative differences in the plasma concentration of endogenous factors that affect 5-HT uptake between patients with PMS and control subjects and that such differences may explain the previously reported alteration of platelet 5-HT uptake and content associated with PMS symptoms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297397     DOI: 10.1007/bf01250999

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  30 in total

1.  Interaction of diet and drugs in the regulation of brain 5-hydroxyindoles and the response to painful electric shock.

Authors:  R B Messing; L A Fisher; L Phebus; L D Lytle
Journal:  Life Sci       Date:  1976-04-01       Impact factor: 5.037

2.  Characterization of the endocoid for imipramine recognition sites.

Authors:  M L Barbaccia; F Karoum; E Costa
Journal:  Prog Clin Biol Res       Date:  1985

Review 3.  Affective disorders and aggression disorders: evidence for a common biological mechanism.

Authors:  H M van Praag
Journal:  Suicide Life Threat Behav       Date:  1986

4.  Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome.

Authors:  C R Ashby; L A Carr; C L Cook; M M Steptoe; D D Franks
Journal:  Biol Psychiatry       Date:  1988-06       Impact factor: 13.382

5.  Demonstration of endogenous "imipramine like" material in rat brain.

Authors:  M Rehavi; I Ventura; Y Sarne
Journal:  Life Sci       Date:  1985-02-18       Impact factor: 5.037

Review 6.  Serotonectin and the family of proteins that bind serotonin.

Authors:  M D Gershon; H Tamir
Journal:  Biochem Pharmacol       Date:  1984-10-15       Impact factor: 5.858

7.  Mass fragmentographic determination of tetrahydro-beta-carboline in human blood platelets and plasma.

Authors:  I Kari; P Peura; M M Airaksinen
Journal:  Med Biol       Date:  1979

8.  Inhibition of synaptosomal 5-[3H]hydroxytryptamine uptake by endogenous factor(s) in human blood.

Authors:  I Angel; S M Paul
Journal:  FEBS Lett       Date:  1984-06-11       Impact factor: 4.124

9.  Serotonin levels and platelet uptake during premenstrual tension.

Authors:  D L Taylor; R J Mathew; B T Ho; M L Weinman
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

10.  Human serotonectin: a blood glycoprotein that binds serotonin and is associated with platelets and white blood cells.

Authors:  H Tamir; R F Payette; Y L Huang; K P Liu; M D Gershon
Journal:  J Cell Sci       Date:  1985-02       Impact factor: 5.285

View more
  4 in total

Review 1.  The pathophysiologic background for current treatments of premenstrual syndromes.

Authors:  Uriel Halbreich
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.

Authors:  B L Parry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Treatment of depression associated with the menstrual cycle: premenstrual dysphoria, postpartum depression, and the perimenopause.

Authors:  Ellen W Freeman
Journal:  Dialogues Clin Neurosci       Date:  2002-06       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.